252 related articles for article (PubMed ID: 26494390)
21. Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Feb; 99(2):E286-92. PubMed ID: 24297798
[TBL] [Abstract][Full Text] [Related]
22. Advances in the management of hereditary medullary thyroid cancer.
Machens A; Ukkat J; Brauckhoff M; Gimm O; Dralle H
J Intern Med; 2005 Jan; 257(1):50-9. PubMed ID: 15606376
[TBL] [Abstract][Full Text] [Related]
23. Prediction of biochemical cure in patients with medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2020 May; 107(6):695-704. PubMed ID: 32108330
[TBL] [Abstract][Full Text] [Related]
24. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
[TBL] [Abstract][Full Text] [Related]
25. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
[TBL] [Abstract][Full Text] [Related]
26. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients.
Prabhu M; Shakya S; Ballal S; Ahmed Shamim S; Bal C
Nucl Med Commun; 2020 Nov; 41(11):1136-1142. PubMed ID: 32796450
[TBL] [Abstract][Full Text] [Related]
27. Current management of medullary thyroid cancer.
Milan SA; Sosa JA; Roman SA
Minerva Chir; 2010 Feb; 65(1):27-37. PubMed ID: 20212415
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations.
Machens A; Elwerr M; Lorenz K; Weber F; Dralle H
Br J Surg; 2018 Jan; 105(2):e150-e157. PubMed ID: 29341155
[TBL] [Abstract][Full Text] [Related]
29. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
30. Single center experience in primary surgery for medullary thyroid carcinoma.
Ukkat J; Gimm O; Brauckhoff M; Bilkenroth U; Dralle H
World J Surg; 2004 Dec; 28(12):1271-4. PubMed ID: 15517488
[TBL] [Abstract][Full Text] [Related]
31. Surgical approaches in thyroid cancer and lymph-node metastases.
Dralle H; Machens A
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):971-87. PubMed ID: 19041826
[TBL] [Abstract][Full Text] [Related]
32. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
33. Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age.
Spinelli C; Strambi S; Rossi L; Elisei R; Massimino M
Curr Pediatr Rev; 2016; 12(4):280-285. PubMed ID: 27834132
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.
Araujo AN; Moraes L; França MI; Hakonarson H; Li J; Pellegrino R; Maciel RM; Cerutti JM
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1104-12. PubMed ID: 24601688
[TBL] [Abstract][Full Text] [Related]
35. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid carcinoma: state of the art.
Favia G; Iacobone M
G Chir; 2005; 26(11-12):405-9. PubMed ID: 16472416
[TBL] [Abstract][Full Text] [Related]
37. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.
Gosnell JE; Sywak MS; Sidhu SB; Gough IR; Learoyd DL; Robinson BG; Delbridge LW
ANZ J Surg; 2006 Jul; 76(7):586-90. PubMed ID: 16813623
[TBL] [Abstract][Full Text] [Related]
38. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
39. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
40. Early malignant progression of hereditary medullary thyroid cancer.
Machens A; Niccoli-Sire P; Hoegel J; Frank-Raue K; van Vroonhoven TJ; Roeher HD; Wahl RA; Lamesch P; Raue F; Conte-Devolx B; Dralle H;
N Engl J Med; 2003 Oct; 349(16):1517-25. PubMed ID: 14561794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
